Cargando…
NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation
BACKGROUND: Advanced mast cell (MC) disorders are characterized by uncontrolled growth of neoplastic MC in various organs, mediator-related symptoms, and a poor prognosis. Kit mutations supposedly contribute to abnormal growth and drug resistance in these patients. METHODS: We established a novel ca...
Autores principales: | Hadzijusufovic, E, Peter, B, Herrmann, H, Rülicke, T, Cerny-Reiterer, S, Schuch, K, Kenner, L, Thaiwong, T, Yuzbasiyan-Gurkan, V, Pickl, W F, Willmann, M, Valent, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401908/ https://www.ncbi.nlm.nih.gov/pubmed/22583069 http://dx.doi.org/10.1111/j.1398-9995.2012.02833.x |
Ejemplares similares
-
In vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells
por: Gamperl, Susanne, et al.
Publicado: (2020) -
Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells
por: Gamperl, Susanne, et al.
Publicado: (2019) -
Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors
por: Webster, Joshua D, et al.
Publicado: (2006) -
Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus Proposal
por: Willmann, Michael, et al.
Publicado: (2021) -
Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms
por: Willmann, Michael, et al.
Publicado: (2018)